We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Syntheticmr Ab (publ) | LSE:0G79 | London | Ordinary Share | SE0015987946 | SYNTHETICMR ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 350.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 89.21M | 10.01M | 0.2404 | 1,455.91 | 14.58B |
STOCKHOLM, June 9, 2021 /PRNewswire/ -- SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems. The project will focus on joint development and evaluation of quantitative MR imaging solutions for clinical practice.
CONTACT:
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/syntheticmr-ab/r/syntheticmr-enters-joint-development-project-with-juntendo-university-hospital-and-canon-medical-sys,c3364064
The following files are available for download:
https://mb.cision.com/Main/11663/3364064/1429843.pdf | Press release SyntheticMR 09062021 EN |
View original content:http://www.prnewswire.com/news-releases/syntheticmr-enters-joint-development-project-with-juntendo-university-hospital-and-canon-medical-systems-301309005.html
SOURCE SyntheticMR AB
Copyright 2021 PR Newswire
1 Year Syntheticmr Ab (publ) Chart |
1 Month Syntheticmr Ab (publ) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions